Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Alaska Energy Metals Extends Eureka Zone Mineralization 1.8 Kilometers to the Southeast, Nikolai Project, Alaska
-
Erdene Provides Corporate Finance Update
-
HPQ Silicon Signs Memorandum of Understanding (MOU) with Company in Northern Germany
-
LAVA Reports Third Quarter 2024 Financial Results and Announces Pipeline Reprioritization and Cash Runway Extension into 2027
-
VR Resources Confirms Mafic-Ultramafic Intrusion with Magmatic Sulfide in First Two Drillholes at Empire Project, Ontario
-
Ampligen Co-Inventor and Former CEO Agrees to Join AIM Scientific Advisory Board if Kellner Group Nominees Are Elected
-
Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
Nayax Enables Discover® Global Network Cardholders to Use Their Preferred Payment Method Across EMEA
-
Psyence Biomed Executes Binding Agreements with Optimi Health Corp.
-
iLearningEngines Special Committee Provides Update
-
ZenaTech Announces Second Land Survey Acquisition With a Signed LOI, Bringing Drone-as-a-Service Innovation to a US $10.3 Billion Industry
-
Bombardier Announces Notice of Partial Redemption for US$300,000,000 of its 7.875% Senior Notes due 2027
-
Ollie’s Bargain Outlet Holdings, Inc. Reports Third Quarter Fiscal 2024 Financial Results
-
Saia Inc. Announces Increase in Borrowing Capacity
-
Coherent Unveils Discovery LX Laser, Expanding the Chameleon Discovery Family
-
Bayport Management Ltd announces the record date and exchange date for the exchange of its outstanding senior and subordinated social bonds.
-
India Blockchain Week 2024 Conference Reveals Remarkable Web3 Ecosystem Growth
-
Cardiff Oncology Prices Oversubscribed $40 Million Underwritten Registered Direct Offering
-
Vow ASA: Final results of the rights issue
-
CANADA CARBON ANNOUNCES PRIVATE PLACEMENT OF FLOW-THROUGH UNITS
-
Form 8.3 - Volex plc - Octopus Investments
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
MEXC's Supercar Giveaway Surpasses 100,000 Participants, with a 12,000,000 USDT Prize Pool in Sight
-
MEXC's Supercar Giveaway Surpasses 100,000 Participants, with a 12,000,000 USDT Prize Pool in Sight
-
Bunzl Canada’s 2024 Week of Giving Brings Vital Community Support
-
uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease
-
Resolutions of Oma Savings Bank Plc’s Extraordinary General Meeting
-
Discover the SPLRG ($SPLRG) Listing on XT
-
Anfield Energy Inc. Provides Update on Proposed Plan of Arrangement
-
Sable Defines Additional Targets within the Copper Queen Project in British Columbia
-
Class 1 Nickel and Technologies Ltd. Completes Private Placement
-
Probe Gold And Midland Report Positive MMI Soil Sampling Results on the La Peltrie Cu-Au-Ag-Mo Mineralized System, Detour Quebec
-
Midland and Probe Gold Announce MMI Soil Results on the Copper-Gold-Silver-Molybdenum Discovery, La Peltrie Project
-
Troilus Announces Positive Environmental Study Results, Confirms Low Acidity and Natural Neutralizing Properties of Ore Zones
-
Scilex Holding Company Enters into a Binding Term Sheet for a Joint Venture with IPMC and Bio Open Innovation Consortium to Develop and Commercialize a Phase 2 Clinical Stage, Potential Best-In-Class
-
Todd Stockard Joins PlanSource as Chief Financial Officer
-
Lantronix to Hold One-on-One Briefings During CES to Preview Pre-Launch Edge AI Solutions
-
OnKure Announces Encouraging Preliminary Safety, Tolerability, and Pharmacokinetic (PK) Data from its First-In-Human PIKture-01 Trial of OKI-219
-
Cellenkos Presents Phase 1b Data at ASH 2024 Showcasing the Potential of T-Regulatory Cell Therapy Candidate CK0804 for Myelofibrosis
-
Beneficient Hires Industry Veteran Louise Jones to Lead Capital Markets and Custody Business Line Operations
-
Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG333, its Novel Half-Life Extended TSLP Antibody for the Treatment of Respiratory and Broader I&I Conditions
-
IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Mee
-
HRCI Announces Board Expansion; Welcomes Two New Directors
-
CervoMed Announces Topline Data from RewinD-LB Phase 2b Clinical Trial in Patients with Dementia with Lewy Bodies
-
MoneyHero Group Reports Third Quarter 2024 Results
-
Microbix Assisting EMQN with Novel Genetic-Test EQA Program
-
Mobilicom Secures Production Orders From U.S. Customer for Use in High Payload Long Range Drones
-
Better Choice Company Increases Capital Stock Distribution of Halo as Part of the SRx Health Transaction from an 8% to 17% Dividend
-
NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Fami
